Seth Landefeld, MD

The pharmaceutical company Parke-Davis employed “the systematic use of deception and misinformation” in order to manipulate physicians into prescribing the drug gabapentin for so-called off-label uses, according to Dr. Landefeld, who is Associate Chief of Staff of Geriatrics and Extended Care at SFVAMC and a UCSF Professor of Medicine. Writing in the New England Journal of Medicine with Michael Steinman, MD, an SFVAMC Staff Physician and UCSF Assistant Professor of Medicine, Dr. Landfeld says the company’s deceptive marketing campaign was, and is, typical of the pharmaceutical industry.
Learn more